AMNEAL PHARMACEUTICALS INC's ticker is AMRX and the CUSIP is 03168L105. A total of 145 filers reported holding AMNEAL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $884,428 | +68.2% | 209,580 | +23.5% | 0.00% | +100.0% |
| Q2 2023 | $525,884 | +103.6% | 169,640 | -8.7% | 0.00% | +100.0% |
| Q1 2023 | $258,256 | -32.7% | 185,796 | -3.7% | 0.00% | -50.0% |
| Q4 2022 | $383,762 | -6.4% | 192,845 | -5.0% | 0.00% | 0.0% |
| Q3 2022 | $410,000 | -36.9% | 202,995 | -0.7% | 0.00% | -33.3% |
| Q2 2022 | $650,000 | -11.3% | 204,335 | +16.3% | 0.00% | 0.0% |
| Q1 2022 | $733,000 | -13.9% | 175,731 | -1.1% | 0.00% | 0.0% |
| Q4 2021 | $851,000 | -11.9% | 177,631 | -1.8% | 0.00% | -25.0% |
| Q3 2021 | $966,000 | +8.2% | 180,910 | +3.7% | 0.00% | 0.0% |
| Q2 2021 | $893,000 | +126.6% | 174,420 | +197.9% | 0.00% | +100.0% |
| Q1 2021 | $394,000 | +258.2% | 58,550 | +143.6% | 0.00% | – |
| Q4 2020 | $110,000 | +18.3% | 24,035 | 0.0% | 0.00% | – |
| Q3 2020 | $93,000 | -18.4% | 24,035 | 0.0% | 0.00% | -100.0% |
| Q2 2020 | $114,000 | +3.6% | 24,035 | -23.9% | 0.00% | 0.0% |
| Q1 2020 | $110,000 | – | 31,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Fosun International Ltd | 21,521,301 | $90,819,890 | 14.58% |
| Eversept Partners, LP | 2,644,988 | $11,161,849 | 0.94% |
| TPG GP A, LLC | 12,328,767 | $52,027,397 | 0.90% |
| Nantahala Capital Management | 2,212,757 | $9,337,835 | 0.80% |
| Rubric Capital Management LP | 4,024,500 | $16,983,390 | 0.64% |
| Hedges Asset Management LLC | 84,600 | $357,012 | 0.31% |
| Signature Wealth Management Partners, LLC | 66,666 | $281,331 | 0.28% |
| Tejara Capital Ltd | 96,672 | $407,956 | 0.23% |
| Tranquilli Financial Advisor LLC | 71,414 | $301,367 | 0.22% |
| EAM Investors, LLC | 230,271 | $971,744 | 0.19% |